Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5‐year analysis of the French early access program (EPA). (21st April 2022) - Manson, Guillaume; Herbaux, Charles; Schiano, Jean‐Marc; Casasnovas, Olivier; Stamatoullas, Aspasia; Deau, Bénédicte; Schmitt, Anna; Regny, Caroline; Bouabdallah, Krimo; Chauchet, Adrien; Ghesquieres, Hervé; Tempescul, Adrian; et al.